The Glucoregulatory and Liporegulatory Peptide Hormones
The Glucoregulatory and Liporegulatory Peptide Hormones
批准号:
7097561
负责人:
Roger Harold Unger
金额:
$29.83万
依托单位国家:
美国
项目类别:
财政年份:
1977
资助国家:
美国
项目状态:
已结题
起止时间:
1977-12-01 至 2009-05-31
关键词:
DNA binding proteinadipocytesfatty acid metabolismgel mobility shift assaygene targetinggenetically modified animalshigh performance liquid chromatographyhormone regulation /control mechanismimmunocytochemistryin situ hybridizationion exchange chromatographylaboratory mouselaboratory ratleptinneurotrophic factorsobesityovereatingpancreatic isletspeptide hormoneperoxisome proliferator activated receptorprotein purificationprotein structure functionreceptor expressiontissue /cell culturetriglycerideswestern blottings
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): 184 million Americans are overweight and 47 million of these have the metabolic syndrome, a cluster of type 2 diabetes, heart disease, liver disease, blood vessel disease, etc. Specific Aim 1 tests the novel hypothesis that they result from impaired partitioning of the surplus lipids that caused obesity. When rats with congenital leptin resistance develop obesity and metabolic syndrome, their organs become overloaded with lipotoxic derivatives of fatty acids (FA), which normally are confined to fat cells. In leptin-responsive rats obesity-induced hyperleptinemia protects nonadipose tissues from ectopic lipid deposition by partitioning surplus calories into the adipocyte storage space through hypothalamic actions that limit the intake of surplus calories and through direct stimulation of oxidation of unutilized FA in nonadipose tissues. Lack of leptin action causes ectopic lipid deposition, functional impairment of the affected tissues (lipotoxicity), and increased lipid-induced apoptosis. The resulting organ failure is clinically identical to the metabolic syndrome. While the best treatment for metabolic syndrome is the intake of calories not exceeding caloric expenditure, new pharmacologic strategies for preventing and reversing this modern plague are emerging. Specific Aim 2 has equally far-reaching public health implications. We have observed that leptinized islets can survive without immuno suppression and function for at least a year when transplanted into insulin-deficient ketoacidotic diabetic rats, whereas unleptinized islets lose all function within 3 weeks. How lipid-lowering protects normal cells against lethal environmental insults is of enormous potential interest in clinical medicine. Elucidation of the mechanism of their year-long survival for a year may not only advance "cure" of Type 1 diabetes and other disorders treated by organ transplantation, but may lead to novel protective weapons against other cytodestructive clinical disorders. The fatty acid (FA) levels in organs may influence their ability to survive various types of injury. Our lab has shown that leptin, an adipocyte hormone, prevents high FA levels in organs by partitioning the excess caused by overeating into fat cells when caloric intake is excessive. When partitioning is impaired, FA spillover causes metabolic syndrome. We also find that by lowering FA, we can make cells resistant to various noxious events. FA-depletion of pancreatic islet transplants makes them resistant to rejection. Using FA-depleted islets we have been able to "cure" insulin-deficient diabetes in rats for ~1 year without immunosuppression.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ectopic Lipids in the Pancreatic Alpha Cell Link Insulin Resistance to Hyperglycemia
-
批准号:9241626
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:Roger Harold Unger
-
依托单位:
Ectopic Lipids in the Pancreatic Alpha Cell Link Insulin Resistance to Hyperglycemia
-
批准号:9412379
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2017
-
负责人:Roger Harold Unger
-
依托单位:
Trihormonal Regulation of Metabolic Homeostasis: Redesigning Therapy of Diabetes
-
批准号:8250818
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Roger Harold Unger
-
依托单位:
Trihormonal Regulation of Metabolic Homeostasis: Redesigning Therapy of Diabetes
-
批准号:8044623
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Roger Harold Unger
-
依托单位:
Trihormonal Regulation of Metabolic Homeostasis: Redesigning Therapy of Diabetes
-
批准号:8392966
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:Roger Harold Unger
-
依托单位:
GLUCOREGULATORY PEPTIDE HORMONES
-
批准号:7357892
-
项目类别:
-
资助金额:$1.17万
-
财政年份:2006
-
负责人:Roger Harold Unger
-
依托单位:
GLUCOREGULATORY PEPTIDE HORMONES
-
批准号:7180731
-
项目类别:
-
资助金额:$1.05万
-
财政年份:2005
-
负责人:Roger Harold Unger
-
依托单位:
GLUCOREGULATORY PEPTIDE HORMONES
-
批准号:6977501
-
项目类别:
-
资助金额:$0.96万
-
财政年份:2004
-
负责人:Roger Harold Unger
-
依托单位:
MOLECULAR MECHANISMS OF B CELL IMPAIRMENT/DESTRUCTION
-
批准号:2142397
-
项目类别:
-
资助金额:$99.62万
-
财政年份:1990
-
负责人:Roger Harold Unger
-
依托单位:
MOLECULAR MECHANISMS OF B-CELL IMPAIRMENT-DESTRUCTION
-
批准号:3095612
-
项目类别:
-
资助金额:$93.39万
-
财政年份:1990
-
负责人:Roger Harold Unger
-
依托单位:
MOLECULAR MECHANISMS OF B CELL IMPAIRMENT/DESTRUCTION
-
批准号:2142398
-
项目类别:
-
资助金额:$7.28万
-
财政年份:1990
-
负责人:Roger Harold Unger
-
依托单位:
MOLECULAR MECHANISMS OF B-CELL IMPAIRMENT-DESTRUCTION
-
批准号:3095608
-
项目类别:
-
资助金额:$97.33万
-
财政年份:1990
-
负责人:Roger Harold Unger
-
依托单位:
MOLECULAR MECHANISMS OF B-CELL IMPAIRMENT-DESTRUCTION
-
批准号:3095610
-
项目类别:
-
资助金额:$6.82万
-
财政年份:1990
-
负责人:Roger Harold Unger
-
依托单位:
MOLECULAR MECHANISMS OF B-CELL IMPAIRMENT-DESTRUCTION
-
批准号:3095613
-
项目类别:
-
资助金额:$94.25万
-
财政年份:1990
-
负责人:Roger Harold Unger
-
依托单位:
MOLECULAR MECHANISMS OF B-CELL IMPAIRMENT-DESTRUCTION
-
批准号:3095611
-
项目类别:
-
资助金额:$88.21万
-
财政年份:1990
-
负责人:Roger Harold Unger
-
依托单位:
MOLECULAR MECHANISMS OF B CELL IMPAIRMENT/DESTRUCTION
-
批准号:2142399
-
项目类别:
-
资助金额:$15.62万
-
财政年份:1990
-
负责人:Roger Harold Unger
-
依托单位:
MOLECULAR MECHANISMS OF B-CELL IMPAIRMENT-DESTRUCTION
-
批准号:3095609
-
项目类别:
-
资助金额:$4.41万
-
财政年份:1990
-
负责人:Roger Harold Unger
-
依托单位:
GLUCOREGULATORY PEPTIDE HORMONES
-
批准号:2608343
-
项目类别:
-
资助金额:$11.64万
-
财政年份:1977
-
负责人:Roger Harold Unger
-
依托单位:
GLUCOREGULATORY PEPTIDE HORMONES
-
批准号:2758327
-
项目类别:
-
资助金额:$16.67万
-
财政年份:1977
-
负责人:Roger Harold Unger
-
依托单位:
GLUCOREGULATORY PEPTIDE HORMONES
-
批准号:2134413
-
项目类别:
-
资助金额:$11.57万
-
财政年份:1977
-
负责人:Roger Harold Unger
-
依托单位:
国内基金
海外基金
支链氨基酸代谢紊乱调控“Adipocytes - Macrophages Crosstalk”诱发2型糖尿病脂肪组织功能和结构障碍的作用及机制
-
批准号:81970721
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:陶凌
-
依托单位: